TY - JOUR
T1 - Pseudotyped adeno-associated viral vectors for gene transfer in dermal fibroblasts
T2 - Implications for wound-healing applications
AU - Balaji, Swathi
AU - King, Alice
AU - Dhamija, Yashu
AU - Le, Louis D.
AU - Shaaban, Aimen F.
AU - Crombleholme, Timothy M.
AU - Keswani, Sundeep G.
N1 - Funding Information:
The authors thank Dr. James Wilson, Dr. Julie Johnston, and Dr. Arbans Sandhu, from University of Pennsylvania, Vector Core. This work was supported in part by a grant from the Wound Healing Foundation 3M Award , and grant National Institutes of Health-NIGMS (NIH-NIGMS) K08 GM098831-02 (to S.G.K.).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2013
Y1 - 2013
N2 - Background: Cell-specific gene transfer and sustained transgene expression are goals of cutaneous gene therapy. Pseudotyping strategy with adeno-associated viral (AAV) vectors has the potential to confer unique cellular tropism and transduction efficiency. We hypothesize that pseudotyped AAV vectors have differential tropism and transduction efficiency under normal and wound conditions in dermal fibroblasts. Materials and methods: Wepackaged AAV2 genome with green fluorescent protein reporter in capsids of other serotypes, AAV5, AAV7, and AAV8, producing pseudotyped vectors AAV2/5, AAV2/7, and AAV2/8, respectively. Murine andhumandermal fibroblasts were transduced by the different pseudotypes for 24 h at multiplicities of infection 102, 10 3, 104, and 105. We assessed transduction efficiency at days 3 and 7. Experiments were repeated in a simulated wound environment by adding 10 ng/mL platelet-derived growth factor-B to culture media. Results: Transduction efficiency of the pseudotyped AAV vectors was dose dependent. Multiplicity of infection 105 resulted in significantly higher gene transfer. Under normal culture conditions, the pseudotyping strategy conferred differential transduction of dermal fibroblasts, with significantly enhanced transduction of murine cells by AAV2/5 and AAV2/ 8 compared with AAV2/2. Adeno-associated virus 2/8 was more efficacious in transducing human cells. Under wound conditions, transduction efficiency of AAV2/2, 2/5, and 2/8 was significantly lower in murine fibroblasts. At day 3 under wound conditions, all vectors demonstrated similar transduction efficiency, but by day 7, the three pseudotyped vectors transduced significantly more murine cells compared with AAV2/2. However, in human cells, there was no significant difference in the transduction efficiency of each pseudotype between normal and wound conditions at both 3 and 7 d. Conclusions: The AAV pseudotyping strategy represents a gene transfer technology that can result in differential transduction of dermal fibroblasts. The differences in transduction efficiency in murine and human dermal fibroblasts in both the normal and wound environment highlight issues with translatability of gene transfer techniques. These data provide a template for using pseudotyped AAV vectors in cutaneous applications.
AB - Background: Cell-specific gene transfer and sustained transgene expression are goals of cutaneous gene therapy. Pseudotyping strategy with adeno-associated viral (AAV) vectors has the potential to confer unique cellular tropism and transduction efficiency. We hypothesize that pseudotyped AAV vectors have differential tropism and transduction efficiency under normal and wound conditions in dermal fibroblasts. Materials and methods: Wepackaged AAV2 genome with green fluorescent protein reporter in capsids of other serotypes, AAV5, AAV7, and AAV8, producing pseudotyped vectors AAV2/5, AAV2/7, and AAV2/8, respectively. Murine andhumandermal fibroblasts were transduced by the different pseudotypes for 24 h at multiplicities of infection 102, 10 3, 104, and 105. We assessed transduction efficiency at days 3 and 7. Experiments were repeated in a simulated wound environment by adding 10 ng/mL platelet-derived growth factor-B to culture media. Results: Transduction efficiency of the pseudotyped AAV vectors was dose dependent. Multiplicity of infection 105 resulted in significantly higher gene transfer. Under normal culture conditions, the pseudotyping strategy conferred differential transduction of dermal fibroblasts, with significantly enhanced transduction of murine cells by AAV2/5 and AAV2/ 8 compared with AAV2/2. Adeno-associated virus 2/8 was more efficacious in transducing human cells. Under wound conditions, transduction efficiency of AAV2/2, 2/5, and 2/8 was significantly lower in murine fibroblasts. At day 3 under wound conditions, all vectors demonstrated similar transduction efficiency, but by day 7, the three pseudotyped vectors transduced significantly more murine cells compared with AAV2/2. However, in human cells, there was no significant difference in the transduction efficiency of each pseudotype between normal and wound conditions at both 3 and 7 d. Conclusions: The AAV pseudotyping strategy represents a gene transfer technology that can result in differential transduction of dermal fibroblasts. The differences in transduction efficiency in murine and human dermal fibroblasts in both the normal and wound environment highlight issues with translatability of gene transfer techniques. These data provide a template for using pseudotyped AAV vectors in cutaneous applications.
KW - Adeno-associated virus
KW - Gene therapy
KW - Pseudotyping
KW - Regenerative medicine
KW - Wound healing
UR - http://www.scopus.com/inward/record.url?scp=84884669881&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884669881&partnerID=8YFLogxK
U2 - 10.1016/j.jss.2013.03.051
DO - 10.1016/j.jss.2013.03.051
M3 - Article
C2 - 23590866
AN - SCOPUS:84884669881
SN - 0022-4804
VL - 184
SP - 691
EP - 698
JO - Journal of Surgical Research
JF - Journal of Surgical Research
IS - 1
ER -